117 related articles for article (PubMed ID: 16364538)
1. Cysteine 390 mutation of the TSH receptor modulates its ectodomain as an inverse agonist on the serpentine domain with decrease in basal constitutive activity.
Ho SC; Goh SS; Su Q; Khoo DH
Mol Cell Endocrinol; 2005 Dec; 245(1-2):158-68. PubMed ID: 16364538
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the mouse TSH receptor equivalent to human constitutively activating TSH receptor mutations also cause constitutive activity.
Neumann S; Krohn K; Chey S; Paschke R
Horm Metab Res; 2001 May; 33(5):263-9. PubMed ID: 11440271
[TBL] [Abstract][Full Text] [Related]
3. Thyrotropin receptor mutations as a tool to understand thyrotropin receptor action.
Wonerow P; Neumann S; Gudermann T; Paschke R
J Mol Med (Berl); 2001 Dec; 79(12):707-21. PubMed ID: 11862314
[TBL] [Abstract][Full Text] [Related]
4. Effects of genetic immunization of Swiss outbred mice with human thyroid stimulating hormone receptor cDNA plasmids harboring gain-of-function mutations.
Ho SC; Goh SS; Kee IH; Chow PK; Yeo CP; Khoo DH
J Mol Endocrinol; 2007 Feb; 38(1-2):277-88. PubMed ID: 17293446
[TBL] [Abstract][Full Text] [Related]
5. Effects of mutations involving the highly conserved S281HCC motif in the extracellular domain of the thyrotropin (TSH) receptor on TSH binding and constitutive activity.
Ho SC; Van Sande J; Lefort A; Vassart G; Costagliola S
Endocrinology; 2001 Jul; 142(7):2760-7. PubMed ID: 11415994
[TBL] [Abstract][Full Text] [Related]
6. Constitutive activation of the thyrotropin receptor by mutating CYS-636 in the sixth transmembrane segment.
Kosugi S; Mori T
Biochem Biophys Res Commun; 1996 May; 222(3):713-7. PubMed ID: 8651910
[TBL] [Abstract][Full Text] [Related]
7. Interactions between the extracellular domain and the extracellular loops as well as the 6th transmembrane domain are necessary for TSH receptor activation.
Neumann S; Claus M; Paschke R
Eur J Endocrinol; 2005 Apr; 152(4):625-34. PubMed ID: 15817920
[TBL] [Abstract][Full Text] [Related]
8. Cysteine-699, a possible palmitoylation site of the thyrotropin receptor, is not crucial for cAMP or phosphoinositide signaling but is necessary for full surface expression.
Kosugi S; Mori T
Biochem Biophys Res Commun; 1996 Apr; 221(3):636-40. PubMed ID: 8630013
[TBL] [Abstract][Full Text] [Related]
9. [Structure-function relations of glycoprotein hormone receptors and their medical applications].
Costagliola S
Bull Mem Acad R Med Belg; 2004; 159(5-6):367-75. PubMed ID: 15693546
[TBL] [Abstract][Full Text] [Related]
10. Identification and evaluation of constitutively active thyroid stimulating hormone receptor mutations.
Lado-Abeal J; Quisenberry LR; Castro-Piedras I
Methods Enzymol; 2010; 484():375-95. PubMed ID: 21036242
[TBL] [Abstract][Full Text] [Related]
11. Detection of mutations in glycoprotein hormone receptors.
Gromoll J; Bröcker M; Derwahl M; Höppner W
Methods; 2000 May; 21(1):83-97. PubMed ID: 10764609
[TBL] [Abstract][Full Text] [Related]
12. A conformational contribution of the luteinizing hormone-receptor ectodomain to receptor activation.
Nurwakagari P; Breit A; Hess C; Salman-Livny H; Ben-Menahem D; Gudermann T
J Mol Endocrinol; 2007 Feb; 38(1-2):259-75. PubMed ID: 17293445
[TBL] [Abstract][Full Text] [Related]
13. Thyroid stimulating autoantibody M22 mimics TSH binding to the TSH receptor leucine rich domain: a comparative structural study of protein-protein interactions.
Núñez Miguel R; Sanders J; Chirgadze DY; Furmaniak J; Rees Smith B
J Mol Endocrinol; 2009 May; 42(5):381-95. PubMed ID: 19221175
[TBL] [Abstract][Full Text] [Related]
14. [A study on the role of the transmembrane V to VI regions of the human luteinizing hormone receptor in its constitutive activation].
Kudo M
Hokkaido Igaku Zasshi; 1999 Jan; 74(1):53-65. PubMed ID: 10331060
[TBL] [Abstract][Full Text] [Related]
15. Current standards, variations, and pitfalls for the determination of constitutive TSHR activity in vitro.
Mueller S; Jaeschke H; Paschke R
Methods Enzymol; 2010; 485():421-36. PubMed ID: 21050930
[TBL] [Abstract][Full Text] [Related]
16. Thyrotropin receptor: a role for thyroid tumourigenesis?
Russo D; Arturi F; Chiefari E; Filetti S
Forum (Genova); 1999; 9(2):166-75. PubMed ID: 10385711
[TBL] [Abstract][Full Text] [Related]
17. FSH and TSH binding to their respective receptors: similarities, differences and implication for glycoprotein hormone specificity.
Núñez Miguel R; Sanders J; Chirgadze DY; Blundell TL; Furmaniak J; Rees Smith B
J Mol Endocrinol; 2008 Sep; 41(3):145-64. PubMed ID: 18606720
[TBL] [Abstract][Full Text] [Related]
18. A tyrosine residue on the TSH receptor stabilizes multimer formation.
Latif R; Michalek K; Morshed SA; Davies TF
PLoS One; 2010 Feb; 5(2):e9449. PubMed ID: 20195479
[TBL] [Abstract][Full Text] [Related]
19. Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist.
Vlaeminck-Guillem V; Ho SC; Rodien P; Vassart G; Costagliola S
Mol Endocrinol; 2002 Apr; 16(4):736-46. PubMed ID: 11923470
[TBL] [Abstract][Full Text] [Related]
20. Role of cysteine residues in the extracellular domain and exoplasmic loops of the transmembrane domain of the TSH receptor: effect of mutation to serine on TSH receptor activity and response to thyroid stimulating autoantibodies.
Kosugi S; Ban T; Akamizu T; Kohn LD
Biochem Biophys Res Commun; 1992 Dec; 189(3):1754-62. PubMed ID: 1336379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
